Company intelligence / Profile preview

PAN-Biotech GmbH

Aidenbach, Bayern/Bavaria, Germanypan-biotech.com ↗

Ownership: Private
Development stage: Commercial

Overview

PAN-Biotech does not develop therapeutics but manufactures GMP-compliant biosolutions—media, reagents, buffers—for use in clinical and commercial bioproduction. Their solutions support upstream/downstream processing from RUO to GMP standards. They have expanded capacity with new facilities meeting EU GMP Annex I requirements.

Therapeutic areas: OtherRare DiseasesInfectious Diseases
Modalities: Cell culture mediaReagentsBuffers
Industry: Chemicals & Materials

Partnerships

Distribution partnerships such as with BIOCOM Africa for African marketsService partnerships via their “Gateway to Europe” platform supporting non-EU biotech/pharma companies entering the EU market

Beyond the preview

Go deeper on PAN-Biotech GmbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PAN-Biotech GmbH.

Explore the full profile